MIC + B12 (Lipotropic Blend)

“MIC + B12” denotes an aqueous solution of three classical lipotropic nutrients — Methionine, Inositol and Choline — together with vitamin B12, supplied as cyanocobalamin, methylcobalamin or a mixture of the two. It is the simplest and most common member of the lipotropic-injection family and differs from broader blends such as Lipo-C mainly in omitting the additional B-vitamins and carnitine. As with all such products there is no pharmacopoeial standard: the ratio of the three MIC components and the form and amount of cobalamin vary by supplier, and the certificate of analysis for the specific lot is the only authoritative statement of what the vial contains. It is offered as a laboratory reference material.

The components and their biochemistry

• Methionine is an essential sulfur amino acid and the precursor of S-adenosylmethionine (SAMe), the methyl donor for more than a hundred transmethylation reactions including the three sequential methylations that convert phosphatidylethanolamine to phosphatidylcholine in the liver. Mato and colleagues review how disrupted hepatic methionine metabolism is associated with steatosis and liver injury in rodents and humans [3].
• Myo-inositol is a cyclic six-carbon polyol that forms the backbone of phosphatidylinositol and the phosphoinositide signalling lipids; its metabolic role and trial record are reviewed by Croze and Soulage [4].
• Choline is an essential nutrient; in a controlled depletion study, healthy adults fed a choline-deficient diet developed fatty liver or muscle damage that reversed with repletion [2]. The 1932 rat experiments of Best and Huntsman, in which choline from lecithin prevented dietary fatty liver, are the origin of the term “lipotropic” [1].
• Vitamin B12 is the cofactor for methionine synthase, which regenerates methionine from homocysteine, tying the vitamin directly to the methionine–SAMe cycle. Cyanocobalamin is the stable synthetic form; methylcobalamin is one of the two coenzyme forms. A 2015 review concluded that coenzyme forms are not likely to be superior to cyano- or hydroxocobalamin for correcting deficiency, because all forms are converted intracellularly to the same active coenzymes [6][7].

How the combination is rationalised

The rationale offered in the trade literature is that the three MIC components support hepatic phosphatidylcholine synthesis and lipoprotein export while B12 keeps the methionine cycle turning. That reasoning is mechanistically coherent in the setting of nutrient deficiency; it does not, on its own, predict any effect on adipose tissue in a replete organism [2][3].

Deficiency versus repletion

A recurring point in the component literature is that the effects of choline, methionine and cobalamin are demonstrable in deficiency and reverse on repletion, but that giving more of a nutrient to an already replete organism does not extend the effect [2][5]. Choline intake above requirement is excreted or converted by gut microbes to trimethylamine; surplus methionine is transaminated or oxidised; excess cobalamin is bound to transport proteins and cleared renally. This distinction matters when interpreting claims about lipotropic mixtures in well-nourished subjects.

Why it is offered as a laboratory reagent

The mixture serves as a multi-analyte calibration or system-suitability sample for HPLC and LC-MS/MS methods for amino acids, polyols and cobalamins; as a defined supplement in cell-culture studies of one-carbon metabolism; and as a reference for laboratories characterising circulating lipotropic products. Cobalamin also provides a convenient visible chromophore (absorbance maximum near 361 and 550 nm) for spectrophotometric checks.

What the research does not establish

Controlled evidence for MIC + B12 injections is thin. No adequately powered randomised trial has tested a methionine–inositol–choline–cobalamin injection against placebo for body weight, body fat or liver fat in people, and the individual-component evidence relates to deficiency states or defined pathways rather than to the mixture. Vitamin B12 injections are an approved treatment only for documented deficiency and malabsorption, and that indication does not transfer to a research mixture [5]. The product has not been evaluated by the FDA, is not a compounded or approved drug, and nothing on this page describes a benefit in a person or animal.

Format. Sterile aqueous solution in a sealed multi-dose glass vial; the characteristic pink-red colour comes from cobalamin. The certificate of analysis lists the concentration of methionine, inositol, choline and the cobalamin form(s); no reconstitution is required.

Storage. Store at 2–8°C protected from light; cobalamins are photolabile and methylcobalamin is particularly light-sensitive. Do not freeze. After first puncture, use within the laboratory’s validated in-use period and discard on fading, cloudiness or precipitate.

Dilution. Miscible with water and common aqueous buffers. The reconstitution calculator can be used in dilution mode to compute the working concentration of any listed component.

Handling. Gloves and eye protection; avoid contact with skin and eyes. For in-vitro laboratory research only — not for human or veterinary use.